Daiichi Sankyo to acquire Zepharma from Astellas
TOKYO, Japan - Takashi Shoda (R), president of Daiichi Sankyo Co., and Masaji Oe, president of Zepharma Inc., stellas Pharma Inc.'s nonprescription drug unit, shake hands at a news conference at Daiichi Sankyo's head office in Tokyo on March 31. They announced Daiichi Sankyo will buy Zepharma for 23.5 billion yen.
- Product Code
- ILEA001114314
- Registered date
- 2006/3/31 00:00:00
- Credit
- Kyodo / Kyodo News Images
- Media source
- 2006 Kyodo News
- Media size
- 1864 × 1228 pixel
- Deployment size
- 476.61(KB)*
*File size when opened in Photoshop, etc.